Tianjin, China · Founded 2016 · Privately Held (backing)
Manufacturer of implantable circulatory support systems intended for cardiac function restoration. Rocket Heart is based in Tianjin, China and was founded in 2016. Its last reported valuation was $455 million in Nov 2023. It has raised $13.8 million.
Last reported valuation
$455.2M
Oct 2026
Priced at
—
Total raised
$13.8M
Last round
—
Cap table — not yet on record
Rocket Heart's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Rocket Heart with a free account
·Watch Rocket Heart: the Monday email on marks, rounds and moves
